Zimmer Biomet Holdings ZBH FX & Other Adjustments

FX & Other Adjustments at other companies

CONMEDCNMD

——

MedtronicMDT

——

Americas-$16.5M—

Asia Pacific$2.5M+37.0%

EMEA-$800K-288%

Revenue$2.1B+9.3%

Gross profit$1.5B+11.1%

Operating income$373.2M+27.7%

Net income$238.1M+30.8%

EPS (diluted)$1.22+34.1%

Cash & equivalents$424.2M-69.4%

Total debt$7.5B+4.1%

Total equity$12.7B+2.2%

Total assets$22.7B+2.4%

Operating cash flow$359.4M-6.1%

CapEx$36.3M-18.6%

Free cash flow$323.1M-4.5%

Market cap$17.44B-7.4%

Enterprise value$24.49B-5.2%

P/E22.9×0.0×

P/S2.1×-0.3×

Gross margin70%-1.0pp

Operating margin14%-3.0pp

Net margin9.1%-2.8pp

FCF margin17.3%-1.6pp

Return on equity6.1%-1.2pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.7×